NIOX Group PLC - Asset Resilience Ratio
NIOX Group PLC (NIOX) has an Asset Resilience Ratio of 2.63% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is NIOX Group PLC's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2017)
This chart shows how NIOX Group PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NIOX asset base.
Liquid Assets Composition Over Time
This chart breaks down NIOX Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read NIOX Group PLC (NIOX) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX10.00 Million | 2.63% |
| Total Liquid Assets | GBX10.00 Million | 2.63% |
Asset Resilience Insights
- Limited Liquidity: NIOX Group PLC maintains only 2.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NIOX Group PLC Industry Peers by Asset Resilience Ratio
Compare NIOX Group PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for NIOX Group PLC (2013–2017)
The table below shows the annual Asset Resilience Ratio data for NIOX Group PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
0.00pp |
| 2017-12-30 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
-2.26pp |
| 2016-12-31 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
0.00pp |
| 2016-12-30 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
-1.74pp |
| 2015-12-31 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
0.00pp |
| 2015-12-30 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
-70.53pp |
| 2014-12-31 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
0.00pp |
| 2014-12-30 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
+59.73pp |
| 2013-12-31 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
0.00pp |
| 2013-12-30 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
-- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more